| Dr J Rush Fisher Jr, MD | |
|
4735 Ogletown Stanton Rd, Ste 3302, Newark, DE 19713-8000 | |
| (302) 623-4144 | |
| (302) 623-4289 |
| Full Name | Dr J Rush Fisher Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 34 Years |
| Location | 4735 Ogletown Stanton Rd, Newark, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073518056 | NPI | - | NPPES |
| 0512017000 | Other | DE | AMERIHEALTH/KEYSTONE |
| 200040677 | Other | DE | RAILROAD MEDICARE |
| 2291465 | Other | DE | AETNA HMO |
| 5579793001 | Other | DE | CIGNA |
| 2613 | Other | DE | MID-ATLANTIC |
| G37821 | Other | DE | COVENTRY |
| 1000034633 | Medicaid | DE | |
| 373895 | Other | DE | INDEPENDENCE BC/PC |
| 510399378 | Other | DE | BCBS |
| 5665641 | Other | DE | AETNA PPO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | C10005347 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
| Chester County Hospital | West chester, PA | Hospital |
| Pennsylvania Hospital | Philadelphia, PA | Hospital |
| Christiana Hospital | Newark, DE | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
In their latest move in the battle over contraception coverage, top Republicans in Congress are going for broke: They're now pushing a bill that would allow employers and insurance companies to pick and choose which health benefits to provide based simply on executives' personal moral beliefs. ... Last week, Sen. Roy Blunt (R-Mo.) offered a "conscience amendment," to the law, pitching it as a way to allay religious employers' qualms about providing birth control to their employees.
The current science and experience does not support the safety and efficaciousness of a biosimilar pathway for plasma protein therapies. At a public hearing last week, the Plasma Protein Therapeutics Association (PPTA) urged the United States Food and Drug Administration (FDA) to make patient safety its top priority by adopting a global approach in its evaluation of plasma protein therapies for the biosimilars process.
To address the latest issues on the early detection of lung cancer, the Biodesign Institute at Arizona State University will host an international research consortium in Scottsdale, Ariz., Feb. 25-26.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
Sectra has secured the first order for the software SyMRI Suite from the Institute of Forensic Medicine at the University of Bern. The software will enhance quality in conjunction with virtual autopsies.
› Verified 1 days ago
| Entity Name | Christiana Spine Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821059387 PECOS PAC ID: 6305862848 Enrollment ID: O20051024000471 |
News Archive
In their latest move in the battle over contraception coverage, top Republicans in Congress are going for broke: They're now pushing a bill that would allow employers and insurance companies to pick and choose which health benefits to provide based simply on executives' personal moral beliefs. ... Last week, Sen. Roy Blunt (R-Mo.) offered a "conscience amendment," to the law, pitching it as a way to allay religious employers' qualms about providing birth control to their employees.
The current science and experience does not support the safety and efficaciousness of a biosimilar pathway for plasma protein therapies. At a public hearing last week, the Plasma Protein Therapeutics Association (PPTA) urged the United States Food and Drug Administration (FDA) to make patient safety its top priority by adopting a global approach in its evaluation of plasma protein therapies for the biosimilars process.
To address the latest issues on the early detection of lung cancer, the Biodesign Institute at Arizona State University will host an international research consortium in Scottsdale, Ariz., Feb. 25-26.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
Sectra has secured the first order for the software SyMRI Suite from the Institute of Forensic Medicine at the University of Bern. The software will enhance quality in conjunction with virtual autopsies.
› Verified 1 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720553001 PECOS PAC ID: 6204730955 Enrollment ID: O20190422001689 |
News Archive
In their latest move in the battle over contraception coverage, top Republicans in Congress are going for broke: They're now pushing a bill that would allow employers and insurance companies to pick and choose which health benefits to provide based simply on executives' personal moral beliefs. ... Last week, Sen. Roy Blunt (R-Mo.) offered a "conscience amendment," to the law, pitching it as a way to allay religious employers' qualms about providing birth control to their employees.
The current science and experience does not support the safety and efficaciousness of a biosimilar pathway for plasma protein therapies. At a public hearing last week, the Plasma Protein Therapeutics Association (PPTA) urged the United States Food and Drug Administration (FDA) to make patient safety its top priority by adopting a global approach in its evaluation of plasma protein therapies for the biosimilars process.
To address the latest issues on the early detection of lung cancer, the Biodesign Institute at Arizona State University will host an international research consortium in Scottsdale, Ariz., Feb. 25-26.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
Sectra has secured the first order for the software SyMRI Suite from the Institute of Forensic Medicine at the University of Bern. The software will enhance quality in conjunction with virtual autopsies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr J Rush Fisher Jr, MD 4735 Ogletown Stanton Rd, Ste 3302, Newark, DE 19713-8000 Ph: (302) 623-4144 | Dr J Rush Fisher Jr, MD 4735 Ogletown Stanton Rd, Ste 3302, Newark, DE 19713-8000 Ph: (302) 623-4144 |
News Archive
In their latest move in the battle over contraception coverage, top Republicans in Congress are going for broke: They're now pushing a bill that would allow employers and insurance companies to pick and choose which health benefits to provide based simply on executives' personal moral beliefs. ... Last week, Sen. Roy Blunt (R-Mo.) offered a "conscience amendment," to the law, pitching it as a way to allay religious employers' qualms about providing birth control to their employees.
The current science and experience does not support the safety and efficaciousness of a biosimilar pathway for plasma protein therapies. At a public hearing last week, the Plasma Protein Therapeutics Association (PPTA) urged the United States Food and Drug Administration (FDA) to make patient safety its top priority by adopting a global approach in its evaluation of plasma protein therapies for the biosimilars process.
To address the latest issues on the early detection of lung cancer, the Biodesign Institute at Arizona State University will host an international research consortium in Scottsdale, Ariz., Feb. 25-26.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
Sectra has secured the first order for the software SyMRI Suite from the Institute of Forensic Medicine at the University of Bern. The software will enhance quality in conjunction with virtual autopsies.
› Verified 1 days ago
Dr. Joseph J Mesa, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1096 Old Churchmans Rd, Newark, DE 19713 Phone: 302-655-9494 Fax: 302-351-4896 | |
Jeremie Michael Axe, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4745 Ogletown Stanton Rd Ste 225, Newark, DE 19713 Phone: 302-731-2888 Fax: 302-731-7049 | |
Alex B Bodenstab, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4745 Ogletown Stanton Rd Ste 225, Newark, DE 19713 Phone: 302-731-2888 Fax: 302-731-7049 | |
James J Rubano, M.D., MBA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4923 Ogletown Stanton Rd Ste 300, Newark, DE 19713 Phone: 302-655-9494 Fax: 302-691-1478 | |
Eric T Johnson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4745 Ogletown Stanton Rd Ste 225, Newark, DE 19713 Phone: 302-731-2888 Fax: 302-731-7049 | |
Dr. Douglas A Palma, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4923 Ogletown Stanton Rd Ste 300, Newark, DE 19713 Phone: 302-655-9494 Fax: 302-691-1478 |